To compare the expression levels of RAF and VEGFR in the thyroid carcinoma tissues from sorafenib sensitive and resistant patients, tumour samples from a total of 16 patients with thyroid carcinoma were collected, including 11 sorafenib sensitive patients and five sorafenib resistant patients. The gene discussed is KDR; the disease is neoplasm.